SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production

SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a major expansion of its small molecule and peptide production capabilities with a $260 million investment to construct a new state-of-the-art facil…